Table 3.

Infection presentation and treatment.

Case	Sex	Age, y	Culture Results	Days to Encounter	Initial WBC	Initial CRP	Initial ESR	Aspiration WBCa	Surgical I&Ds	Days to Initial I&D	Antibiotic Type	Antibiotic Duration (Weeks)
1	M	47	Neg	42	10.3	10.2	82	62	1	53	Gatifloxacin	4
2	M	21	Neg	42	11.6	18.2	83	235	3	43	Augmentin	2
3	F	23	Staph epi	19	5.7	9.23	86	10	2	22	Gatifloxacin	6
4	F	16	Neg	22	8.7	23	97	54	4	22	Vancomycin / Linezolid	4
5	M	24	CNS	10	11.1	23	34	27	2	10	Gatifloxacin	8
Average		26.0		27.0	9.5	16.7	76.4	77.5	2.4	30.0		4.8
Range		16-47		7-42	5.7-11.6	9.23-23.0	34-97	10-235	1-4	7-53		2-8

WBC, white blood cell; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; I&D, irrigation and debridement; staph epi, Staphylococcus epidermidis; CNS, coagulase-negative staphylococci (unable to further identify).

^aIn thousands.